Majowicz, SE, et al.
The global burden of nontyphoidal salmonella gastroenteritis. Clinical Infectious Diseases
2010; 50: 882–889.
Polo, F, et al.
Prevalence of Salmonella serotypes in environmental waters and their relationships with indicator organisms. Antonie Van Leeuwenhoek
1999; 75: 285–292.
Synnott, M, et al.
An outbreak of Salmonella Mikawasima associated with doner kebabs. Epidemiology and Infection. 1993; 111: 473–481.
Sachs, G, Shin, JM, Howden, CW. Review article: the clinical pharmacology of proton pump inhibitors. Alimentary Pharmacology and Therapy
2006; 23 (Suppl. 2): 2–8.
Neal, KR, et al.
Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study. British Medical Journal
1996; 312: 414–415.
Tam, CC, et al.
Chicken consumption and use of acid-suppressing medications as risk factors for Campylobacter enteritis, England. Emerging Infectious Diseases
2009; 15: 1402–1408.
Bouwknegt, M, et al.
Potential association between the recent increase in campylobacteriosis incidence in the Netherlands and proton-pump inhibitor use – an ecological study. Eurosurveillance
Dial, S, et al.
Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. Canadian Medical Association Journal
2004; 171: 33–38.
Jayatilaka, S, et al.
Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors. Annals of Clinical and Laboratory Science
2007; 37: 241–247.
Doorduyn, Y, et al.
Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections. Epidemiology and Infection
2006; 134: 617–626.
Brophy, S, et al.
Incidence of Campylobacter and Salmonella infections following first prescription for PPI: a cohort study using routine data. American Journal of Gastroenterology
2013; 108: 1094–1100.
Farrington, CP, et al.
A Statistical algorithm for the early detection of outbreaks of infectious disease. Journal of the Royal Statisitcal Society Series A (Statistics in Society)
1996; 159: 547–563.
Grimont, PA, Weill, FX. Antigenic Formulae of the Salmonella Serovars, 9th edn. World Health Organization Collaborating Center for Reference and Research on Salmonella, Institut Pasteur, 2007.
National Institute for Health and Care Excellence. Dyspepsia and gastro-oesophageal reflux disease: investigation and management of dyspepsia, symptoms suggestive of gastro-oesophageal reflux disease, or both (https://www.nice.org.uk/guidance/cg184). Accessed 16 April 2015.
Batuwitage, BT, et al.
Inappropriate prescribing of proton pump inhibitors in primary care. Postgraduate Medical Journal
2007; 83: 66–68.
Wu, HH, et al.
Association between recent use of proton pump inhibitors and nontyphoid salmonellosis: a nested case-control study. Clinical Infectious Diseases
2014; 59: 1554–1558.
Bavishi, C, Dupont, HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Alimentary Pharmacology and Therapy
2011; 34: 1269–1281.
Bowen, A, et al.
Role of acid-suppressing medications during a sustained outbreak of Salmonella enteritidis infection in a long-term care facility. Infection Control and Hospital Epidemiology
2007; 28: 1202–1205.
Mook, P, et al. Selection of population controls for a Salmonella case-control study in the UK using a market research panel and web-surverys provides time and resource savings. Epidemiology and Infection (in press).
Parkin, L, Hagberg, KW, Jick, H. Comprehensive comparison of drug prescribing in the United States and United Kingdom. Pharmacotherapy
2011; 31: 623–629.
Garcia Rodriguez, LA, Ruigomez, A, Panes, J. Use of acid-suppressing drugs and the risk of bacterial gastroenteritis. Clinical Gastroenterology and Hepatology
2007; 5: 1418–1423.
Doorduyn, Y, et al.
Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in The Netherlands: a case-control study. Epidemiology and Infection
2010; 138: 1391–404.
Karatzas, KA, et al.
Effects of repeated cycles of acid challenge and growth on the phenotype and virulence of Salmonella enterica
. Journal of Applied Microbiology
2008; 105: 1640–1648.
Riesenberg-Wilmes, MR, et al.
Role of the acid tolerance response in virulence of Salmonella Typhimurium. Infection and Immunity
1996; 64: 1085–1092.